Breast Cancer, Counseling
Conditions
Keywords
Daughters, Communication, genetic risk, Genetic Counseling
Brief summary
The purpose of this study is to first understand how MSKCC Clinical Genetics Service doctors talk to women with breast cancer about any genetic risks they might carry, and if they help women to think about what they might say, in turn, to their relatives, especially their daughters. A second part of the study asks women for their opinions about when and how their daughters should be told about any genetic risks. All of this will help us develop teaching methods to help our doctors improve the way they talk about genetic risk when women with breast cancer have adolescent daughters.
Interventions
BEHAVIORALfocus group & questionaire
The focus group will last about 90 minutes. However, your involvement in this study will last from the time you join until you read over the summary of what happened during the focus group and return your comments. This should be approximately 2 months. Patient will complete a questionnaire and we estimate total time for completion to be approximately 7 minutes.
Sponsors
Monash University
Memorial Sloan Kettering Cancer Center
Study design
Observational model
FAMILY_BASED
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
12 Years to 20 Years
Healthy volunteers
Yes
Inclusion criteria
* Women seen in the MSK CGS Service who have a diagnosis of breast cancer or * a family history of breast cancer and * have biological daughter(s) in the age range 12-20 years will be eligible to participate in Phase I & II. * Women who were consented to Phase I will automatically be eligible for Phase II.
Exclusion criteria
* Women seen in the MSK CGS Service will be ineligible if they have no diagnosis of breast cancer and no family history of breast cancer, * do not have a biological daughter, * or have a biological daughter fewer than 12 or greater than 20 years(unless they were consented to Phase 1). * Women will be ineligible if they are not English speaking, * have intellectual or cognitive impairment, * or active mental illness rendering them incapable of giving informed consent, such as might occur with active psychosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Is a demonstration of the effectiveness of the module in changing the behavior of clinicians after taking part in the communication skills module. | conclusion of study |
Secondary
| Measure | Time frame |
|---|---|
| To examine the views of women about the provision of genetic risk information to their daughters. | conclusion of study |
Countries
United States
Outcome results
None listed